BCM
NTUS

Bayesian Capital Management’s Natus Medical Inc NTUS Stock Holding History

Bayesian Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,175
Closed -$424K – 752
2016
Q4 		$424K Buy
+12,175
New +$478K 0.11% 343
2016
Q2 		– Sell
-7,186
Closed -$276K – 583
2016
Q1 		$276K Buy
+7,186
New +$268K 0.26% 177

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's NTUS Position: Q1 2017 in Review

Bayesian Capital Management sold out of Natus Medical Inc (NTUS) in Q1 2017, closing a stake of 12,175 shares — an estimated $424K sold.

Bayesian Capital Management first reported a position in NTUS in Q1 2016 and held it in 2 quarters. The position peaked at $424K in Q4 2016. 212 funds tracked by Wall St. Rank hold NTUS as of Q1 2017.

  • Bayesian Capital Management reported no remaining Natus Medical Inc position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 12,175 Natus Medical Inc shares in Q1 2017, an estimated $424K.
  • Bayesian Capital Management first reported a position in Natus Medical Inc in Q1 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Natus Medical Inc position peaked at $424K in Q4 2016.
  • 212 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.